Purdue has been sued hundreds of times over the past 20 years over its marketing of OxyContin to doctors and the drug’s risk of addiction to patients, but Everett’s suit is the first to focus narrowly on what the company knew about criminal distribution of the painkiller.
The Times’ investigation, published in July, disclosed that for more than a decade, an internal security team at Purdue monitored doctors and pharmacies it suspected of colluding with dealers and addicts. In the case of the L.A. ring, criminals set up a phony clinic near MacArthur Park in 2008 and worked with corrupt physicians and pharmacies to obtain pills over 18 months.
A Purdue sales manager dispatched to investigate the high volume of prescriptions at the clinic found a rundown building thronged with rough men and urged supervisors to alert the Drug Enforcement Administration, saying she was “very certain this is an organized drug ring.”
Despite her pleas and additional evidence suggesting that pills were pouring into the hands of criminals, company officials did not go to authorities until years later when the drug ring was out of business and its leaders under indictment. By then, 1.1 million pills had spilled into the illicit pipeline.
Within days of The Times’ story, Everett officials quietly began looking into a lawsuit
Friday, January 20, 2017
"City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens' welfare"
Labels: corruption, crime, law, medicine, politics